Current Edition

Regeneron v Kymab
Volume 12 Issue 3

Regeneron v Kymab: Transgenic Mice Claims Found Insufficient

A patent reflects a bargain between the inventor and the public. The inventor gains a time-limited monopoly over the making and use of a product. …

Continue Reading →
Returning to Basics of siRNA Design to Fulfil
Volume 12 Issue 3

Returning to Basics of siRNA Design to Fulfil Therapeutic Potential

The recent FDA approval of siRNA therapeutics has re-energised the RNA interference (RNAi) field. The discovery of RNAi mediated silencing in mammalian cells and parallel …

Continue Reading →
Diagnostic Techniques for COVID-19
Volume 12 Issue 3

Diagnostic Techniques for COVID-19

SARS-CoV-2, or the pathogen which causes COVID-19, is a virus containing a positive-sense RNA as its genetic constituent.Morphologically, it contains spike-like projections on its surface …

Continue Reading →
Pharma’s Quantum Leap_ Launching New Medicine in
Volume 12 Issue 3

Pharma’s Quantum Leap: Launching New Medicine in the Age of AI

The pharmaceutical industry has long been squeezed by tight regulation, cost controls on medicines, and the necessarily extensive drug discovery and research process. There is …

Continue Reading →
Trapped Ion Mobility Mass Spectrometry
Volume 12 Issue 3

Trapped Ion Mobility Mass Spectrometry (TIMS) Drives High-throughput Phosphoproteomics Research

Unlike genomic and transcriptomic research, the measurement technologies for proteomics are still evolving, and the complete analysis of a proteome has not yet been achieved. …

Continue Reading →
Calcium Bioavailability is Key
Volume 12 Issue 3

Calcium Bioavailability is Key

For the first time in history, most people can expect to live into their 60s and beyond. According to the World Health Organisation, one in …

Continue Reading →
Using Phase-appropriate Delivery to Accelerate
Volume 12 Issue 3

Using Phase-appropriate Delivery to Accelerate Inhaled Product Development

Different inhaled product development programmes can use different platform delivery technologies at various stages of development. Sandy Munro at Vectura shows why careful thought must …

Continue Reading →
Advanced Capsule Development
Volume 12 Issue 3

Advanced Capsule Development for Today’s Needs: HPMC+

The use of compounds (from biologic or chemical origin) as therapeutics is as old as mankind. Traditionally, the administering of such therapeutic products to the …

Continue Reading →
Automated Quality Control of Pharmaceutical
Volume 12 Issue 3

Automated Quality Control of Pharmaceutical Packaging Materials

Inspection systems help print shops perform a 100% print inspection and save time at the implementation of new jobs, due to automated job setups and …

Continue Reading →
Creating a Fit-for-purpose Supply Chain for the
Volume 12 Issue 3

Creating a Fit-for-purpose Supply Chain for the COVID-19 Vaccine

The race is on amongst the international scientific research community to develop a vaccine that will prevent infection by SARS-CoV-2, the virus that causes COVID-19. …

Continue Reading →